Invention Grant
- Patent Title: Method for detecting HIV-1-specific antibodies using clade C env polypeptides
-
Application No.: US16174471Application Date: 2018-10-30
-
Publication No.: US11237166B2Publication Date: 2022-02-01
- Inventor: Rudolf Valenta , Daniela Gallerano , Elopy N. Sibanda
- Applicant: Viravaxx AG
- Applicant Address: AT Vienna
- Assignee: Viravaxx AG
- Current Assignee: Viravaxx AG
- Current Assignee Address: AT Vienna
- Agency: The Webb Law Firm
- Priority: EP13159417 20130315
- Main IPC: G01N33/569
- IPC: G01N33/569 ; C07K14/16 ; C07K14/005 ; C12N7/00 ; G01N33/543

Abstract:
The present invention relates to a method for detecting and/or quantifying human immunodeficiency virus (HIV) specific antibodies in a sample of a subject comprising the step of determining the presence and/or amount of antibodies binding to a) a peptide consisting of the amino acid sequence AIVCTRPNNNTRKSIRIGPGQVFYT (SEQ. ID No. 1), or b) a homolog having at least 70% identity with a peptide of a), or c) a fragment of a peptide of a) or b) consisting of 15 to 24 amino acid residues in said sample.
Public/Granted literature
- US20190219576A1 Method for Diagnosing a Viral Infection Public/Granted day:2019-07-18
Information query
IPC分类: